Searched for
CIPLA STOCK TARGET
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...- NLC India shares rally 18% to fresh record high after Q4 net profit skyrockets 189% YoYNLC India shares rose to a record high on Thursday after the company posted a 189% YoY surge in Q4 net profit to Rs 1,394 crore. Revenue ro...
- Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked targetCipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the stock despit...
- Q4 earnings, crude oil, FII action among 8 factors to steer D-Street this weekIndian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...
- Pharma stocks buck market weakness as Dr Reddy's gainsPharma stocks showed strength on Thursday, defying market weakness. Dr Reddy's Laboratories saw significant gains, fueled by anticipation o...
- Cipla shares rally 6% in 2 days as Q1 results impress; brokerages raise target up to Rs 1,875Cipla shares: Following the earnings announcement, several brokerage firms revised their target price for the stock, with some estimates re...
- Cipla stock in focus after Q2 PAT beats estimates. Should you buy, sell or hold?Cipla's shares are in focus as the company reported a 15% YoY increase in consolidated net profit to Rs 1,303 crore for Q2 2024. Revenue ro...
- Market Trading Guide: Cipla, Petronet LNG among 6 stock recommendations for TuesdayThe Sensex came under selling pressure at the fag-end of the session and ended 203.28 points lower at 76,490.08.
- Cipla surges 10% with rise in price targetsThe average price target of the 28 analysts, whose ratings and price targets that have been compiled by Bloomberg, is ₹1,161. The stock clo...
- Cipla shares jump 9% after Q1 profit soars 45% YoY to Rs 996 crore. Should you buy, sell or hold?In morning session, the scrip was trading 8.5% higher at Rs 1.160 on BSE. Meanwhile, in the last one year, it has surged 19%.
- Buy Cipla, target price Rs 1,090: ICICI DirectICICI Direct has issued a buy call on Cipla with a target price of Rs 1090, higher than the current market price of Rs 914.45. Analysts pro...
- Hold Cipla, target price Rs 1080: Sharekhan by BNP ParibasCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 77400.61 Crore) operating in Pharmaceuticals sector.
- Hold Cipla, target price Rs 1080: Sharekhan by BNP ParibasCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 77566.07 Crore) operating in Pharmaceuticals sector.
- Buy Cipla, target price Rs 1260: Axis SecuritiesCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 86522.68 Crore) operating in Pharmaceuticals sector.
- Buy Cipla, target price Rs 1230: Axis SecuritiesCipla key Products/Revenue Segments include Pharmaceuticals, Royalty Income, Other Operating Revenue, Export Incentives and Scrap for the y...
- Hold Cipla, target price Rs 1210: Sharekhan by BNP ParibasCipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 89460.16 Crore) operating in Pharmaceuticals sector.
- Brokerages see up to 20% upside in Cipla post Q1 results; time to buy?Cipla is on track to launch key products, such as gAdvair, gAbraxane, gRevlimid and three peptide products over FY23-24, it said, adding th...
- Dispute settlement gives this stock an edge over peers in pharma packKunal Dhamesha of Emkay Global raised his price target for the stock to Rs 1,000 and sees potential gain of Rs 45 per share from the settle...
- Brokerages raise targets on CiplaCipla’s shares hit a record high of Rs 814.45 on Monday before ending at Rs 795.65, up 9.2 per cent from the previous close. Cipla reported...
- Brokerages slash Cipla’s target price on weak Q4 earningsCipla reported a consolidated net loss of Rs 61.8 crore for the quarter ended March.
Load More
